Literature DB >> 16934428

Determination of fexofenadine enantiomers in human plasma with high-performance liquid chromatography.

Masatomo Miura1, Tsukasa Uno, Tomonori Tateishi, Toshio Suzuki.   

Abstract

A simple and sensitive high-performance liquid chromatography (HPLC) method was developed as an assay for fexofenadine enantiomers in human plasma. Fexofenadine enantiomers were separated using a mobile phase of 0.5% KH(2)PO(4)-acetonitrile (65:35, v/v) on a Chiral CD-Ph column at a flow rate of 0.5 ml/min and measurement at 220 nm. Analysis required 400 microl of plasma and involved solid-phase extraction with an Oasis HLB cartridge, which gave recoveries for both enantiomers from 67.4 to 71.8%. The lower limit of quantification was 25 ng/ml for (R)- and (S)-fexofenadine. The linear range of this assay was between 25 and 625 ng/ml (regression line r(2)>0.993). Inter- and intra-day coefficients of variation were less than 13.6% and accuracies were within 8.8% over the linear range for both analytes. This method can be applied effectively to measure fexofenadine enantiomer concentrations in clinical samples.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16934428     DOI: 10.1016/j.jpba.2006.07.033

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  10 in total

1.  Carbamazepine differentially affects the pharmacokinetics of fexofenadine enantiomers.

Authors:  Yumiko Akamine; Masatomo Miura; Norio Yasui-Furukori; Midori Kojima; Tsukasa Uno
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

2.  Validated spectroflurimetric determination of some H1 receptor antagonist drugs in pharmaceutical preparations through charge transfer complexation.

Authors:  Mohie K Sharaf el-Din; Fawzia Ibrahim; Manal I Eid; Mary E K Wahba
Journal:  J Fluoresc       Date:  2011-08-10       Impact factor: 2.217

3.  Spectrofluorimetric determination of etodolac, moxepril HCl and fexofenadine HCl using europium sensitized fluorescence in bulk and pharmaceutical preparations.

Authors:  Soad S Abd el-Hay; Christa L Colyer; Wafaa S Hassan; Abdalla Shalaby
Journal:  J Fluoresc       Date:  2011-08-19       Impact factor: 2.217

4.  Effects of one-time apple juice ingestion on the pharmacokinetics of fexofenadine enantiomers.

Authors:  Yumiko Akamine; Masatomo Miura; Hisakazu Komori; Shun Saito; Hiroyuki Kusuhara; Ikumi Tamai; Ichiro Ieiri; Tsukasa Uno; Norio Yasui-Furukori
Journal:  Eur J Clin Pharmacol       Date:  2014-06-07       Impact factor: 2.953

5.  The different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers.

Authors:  Tomonori Tateishi; Masatomo Miura; Toshio Suzuki; Tsukasa Uno
Journal:  Br J Clin Pharmacol       Date:  2008-02-20       Impact factor: 4.335

6.  Validation and application of a liquid chromatography-tandem mass spectrometric method for quantification of the drug transport probe fexofenadine in human plasma using 96-well filter plates.

Authors:  Melonie L Stanton; Melanie S Joy; Reginald F Frye
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-12-24       Impact factor: 3.205

7.  Enhancement of the Oral Bioavailability of Fexofenadine Hydrochloride via Cremophor(®) El-Based Liquisolid Tablets.

Authors:  Soad Ali Yehia; Mohamed Shafik El-Ridi; Mina Ibrahim Tadros; Nolwa Gamal El-Sherif
Journal:  Adv Pharm Bull       Date:  2015-11-30

8.  Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil.

Authors:  Takashi Sakugawa; Masatomo Miura; Nobuo Hokama; Toshio Suzuki; Tomonori Tateishi; Tsukasa Uno
Journal:  Br J Clin Pharmacol       Date:  2009-01-23       Impact factor: 4.335

9.  Identification and Characterization of an Oxidative Degradation Product of Fexofenadine, Development and Validation of a Stability-Indicating RP-UPLC Method for the Estimation of Process Related Impurities and Degradation Products of Fexofenadine in Pharmaceutical Formulations.

Authors:  Bhupendrasinh Vaghela; Surendra Singh Rao; Annarapu Malleshwar Reddy; Panuganti Venkatesh; Navneet Kumar
Journal:  Sci Pharm       Date:  2012-01-21

10.  Stability-indicating HPLC Method for Simultaneous Determination of Montelukast and Fexofenadine Hydrochloride.

Authors:  Mona Pankhaniya; Parula Patel; J S Shah
Journal:  Indian J Pharm Sci       Date:  2013-05       Impact factor: 0.975

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.